The Attributable Direct Medical Cost of Healthcare Associated Infection Caused by Multidrug Resistance Organisms in 68 Hospitals of China
Healthcare associated infection (HAI) is known to increase the economic burden of patients while the medical cost due to MDRO HAI is even higher. Three hundred eighty-one multidrug resistance organisms (MDROs) healthcare associated infection (HAI) case-patients and three hundred eighty-one matched c...
Gespeichert in:
| Veröffentlicht in: | BioMed research international 2019-01, Vol.2019 (2019), p.1-7 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 7 |
|---|---|
| container_issue | 2019 |
| container_start_page | 1 |
| container_title | BioMed research international |
| container_volume | 2019 |
| creator | Yang, Huai Luo, Xiaoli Xing, Yawei Wu, Yinghong Ding, Lili Liu, Weiping Lin, Ling Li, Ying Chen, Meilian Li, Liuyi Wen, Jianguo Liu, Yunxi Wu, Anhua Yang, Yun Ma, Hongqiu Hou, Tieying Li, Weiguang Jia, Huixue Zhang, Weihong |
| description | Healthcare associated infection (HAI) is known to increase the economic burden of patients while the medical cost due to MDRO HAI is even higher. Three hundred eighty-one multidrug resistance organisms (MDROs) healthcare associated infection (HAI) case-patients and three hundred eighty-one matched control-patients were identified between January and December in 2015. The average total hospitalization medical cost of the case group was $6127.65 and that of the control group was $2274.02. The difference between the case group and the control group was statistically significant (t = 21.07; P < 0.01). The attributable cost of MDRO HAI was $3853.63. The direct medical costs due to different MDRO infections were different. The increased medical costs of CR-AB, CR-KP, and CR-PA were significantly higher than that of MRSA, MRSE, ESBL E. coli, and ESBL Kp (P < 0. 05). Among the subitem expenses, the drug cost increased the most (the average cost was $1457.72), followed by the treatment fee and test fee; the differences were statistically significant (P < 0.01). |
| doi_str_mv | 10.1155/2019/7634528 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6425381</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A624417461</galeid><sourcerecordid>A624417461</sourcerecordid><originalsourceid>FETCH-LOGICAL-c565t-853317147a6e487fc4a600f28abb356b3d1c854b7ee35cb76e7e781ba770de3</originalsourceid><addsrcrecordid>eNqNkktvEzEQgFcIRKvSG2dkiQsShPpt7wUpCo9UalUJere83tnE1cYOtreoP4F_jaOEFDjhi1-fvvF4pmleEvyeECEuKCbthZKMC6qfNKeUET6ThJOnxzVjJ815zne4Dk0kbuXz5oThlrcCt6fNz9s1oHkpyXdTsd0I6KNP4Aq6ht47O6JFzAXFAS3BjmXtbKp4ztF5W6BHl2GosI8BLeyU60H3gK6nsfg-TSv0FbLPxQYH6CatbPB5k5EPSGq0jHnrix3zzr1Y-2BfNM-Guofzw3zWfPv86XaxnF3dfLlczK9mTkhRZlowRhThykrgWg2OW4nxQLXtOiZkx3ritOCdAmDCdUqCAqVJZ5XCPbCz5sPeup26DfQOQkl2NNvkNzY9mGi9-fsm-LVZxXsjORVMkyp4cxCk-H2CXMzGZwfjaAPEKRtKMZctlVxV9PU_6F2cUqjJGUpaVkujiX6kVnYE48MQa1y3k5q5pJwTxeUu7Ls95VLMOcFwfDLBZtcKZtcK5tAKFX_1Z5pH-HfhK_B2D9Sv7-0P_586qAwM9pEmVHEt2S9TDsTz</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2193133818</pqid></control><display><type>article</type><title>The Attributable Direct Medical Cost of Healthcare Associated Infection Caused by Multidrug Resistance Organisms in 68 Hospitals of China</title><source>Wiley Online Library Open Access</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>PubMed Central Open Access</source><creator>Yang, Huai ; Luo, Xiaoli ; Xing, Yawei ; Wu, Yinghong ; Ding, Lili ; Liu, Weiping ; Lin, Ling ; Li, Ying ; Chen, Meilian ; Li, Liuyi ; Wen, Jianguo ; Liu, Yunxi ; Wu, Anhua ; Yang, Yun ; Ma, Hongqiu ; Hou, Tieying ; Li, Weiguang ; Jia, Huixue ; Zhang, Weihong</creator><contributor>Liu, Yatao</contributor><creatorcontrib>Yang, Huai ; Luo, Xiaoli ; Xing, Yawei ; Wu, Yinghong ; Ding, Lili ; Liu, Weiping ; Lin, Ling ; Li, Ying ; Chen, Meilian ; Li, Liuyi ; Wen, Jianguo ; Liu, Yunxi ; Wu, Anhua ; Yang, Yun ; Ma, Hongqiu ; Hou, Tieying ; Li, Weiguang ; Jia, Huixue ; Zhang, Weihong ; Liu, Yatao</creatorcontrib><description>Healthcare associated infection (HAI) is known to increase the economic burden of patients while the medical cost due to MDRO HAI is even higher. Three hundred eighty-one multidrug resistance organisms (MDROs) healthcare associated infection (HAI) case-patients and three hundred eighty-one matched control-patients were identified between January and December in 2015. The average total hospitalization medical cost of the case group was $6127.65 and that of the control group was $2274.02. The difference between the case group and the control group was statistically significant (t = 21.07; P < 0.01). The attributable cost of MDRO HAI was $3853.63. The direct medical costs due to different MDRO infections were different. The increased medical costs of CR-AB, CR-KP, and CR-PA were significantly higher than that of MRSA, MRSE, ESBL E. coli, and ESBL Kp (P < 0. 05). Among the subitem expenses, the drug cost increased the most (the average cost was $1457.72), followed by the treatment fee and test fee; the differences were statistically significant (P < 0.01).</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2019/7634528</identifier><identifier>PMID: 30949509</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Beta lactamases ; China ; Cross infection ; Drug resistance ; Drug resistance in microorganisms ; E coli ; Economic aspects ; Epidemiology ; Escherichia coli ; Health aspects ; Health care ; Hospitals ; Infections ; Medical care, Cost of ; Methicillin ; Mortality ; Multidrug resistance ; Multidrug resistant organisms ; Nosocomial infections ; Patients ; Staphylococcus aureus infections ; Statistical analysis ; Statistical significance</subject><ispartof>BioMed research international, 2019-01, Vol.2019 (2019), p.1-7</ispartof><rights>Copyright © 2019 Huixue Jia et al.</rights><rights>COPYRIGHT 2019 John Wiley & Sons, Inc.</rights><rights>Copyright © 2019 Huixue Jia et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2019 Huixue Jia et al. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c565t-853317147a6e487fc4a600f28abb356b3d1c854b7ee35cb76e7e781ba770de3</citedby><cites>FETCH-LOGICAL-c565t-853317147a6e487fc4a600f28abb356b3d1c854b7ee35cb76e7e781ba770de3</cites><orcidid>0000-0002-3628-7379</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425381/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425381/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30949509$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Liu, Yatao</contributor><creatorcontrib>Yang, Huai</creatorcontrib><creatorcontrib>Luo, Xiaoli</creatorcontrib><creatorcontrib>Xing, Yawei</creatorcontrib><creatorcontrib>Wu, Yinghong</creatorcontrib><creatorcontrib>Ding, Lili</creatorcontrib><creatorcontrib>Liu, Weiping</creatorcontrib><creatorcontrib>Lin, Ling</creatorcontrib><creatorcontrib>Li, Ying</creatorcontrib><creatorcontrib>Chen, Meilian</creatorcontrib><creatorcontrib>Li, Liuyi</creatorcontrib><creatorcontrib>Wen, Jianguo</creatorcontrib><creatorcontrib>Liu, Yunxi</creatorcontrib><creatorcontrib>Wu, Anhua</creatorcontrib><creatorcontrib>Yang, Yun</creatorcontrib><creatorcontrib>Ma, Hongqiu</creatorcontrib><creatorcontrib>Hou, Tieying</creatorcontrib><creatorcontrib>Li, Weiguang</creatorcontrib><creatorcontrib>Jia, Huixue</creatorcontrib><creatorcontrib>Zhang, Weihong</creatorcontrib><title>The Attributable Direct Medical Cost of Healthcare Associated Infection Caused by Multidrug Resistance Organisms in 68 Hospitals of China</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>Healthcare associated infection (HAI) is known to increase the economic burden of patients while the medical cost due to MDRO HAI is even higher. Three hundred eighty-one multidrug resistance organisms (MDROs) healthcare associated infection (HAI) case-patients and three hundred eighty-one matched control-patients were identified between January and December in 2015. The average total hospitalization medical cost of the case group was $6127.65 and that of the control group was $2274.02. The difference between the case group and the control group was statistically significant (t = 21.07; P < 0.01). The attributable cost of MDRO HAI was $3853.63. The direct medical costs due to different MDRO infections were different. The increased medical costs of CR-AB, CR-KP, and CR-PA were significantly higher than that of MRSA, MRSE, ESBL E. coli, and ESBL Kp (P < 0. 05). Among the subitem expenses, the drug cost increased the most (the average cost was $1457.72), followed by the treatment fee and test fee; the differences were statistically significant (P < 0.01).</description><subject>Beta lactamases</subject><subject>China</subject><subject>Cross infection</subject><subject>Drug resistance</subject><subject>Drug resistance in microorganisms</subject><subject>E coli</subject><subject>Economic aspects</subject><subject>Epidemiology</subject><subject>Escherichia coli</subject><subject>Health aspects</subject><subject>Health care</subject><subject>Hospitals</subject><subject>Infections</subject><subject>Medical care, Cost of</subject><subject>Methicillin</subject><subject>Mortality</subject><subject>Multidrug resistance</subject><subject>Multidrug resistant organisms</subject><subject>Nosocomial infections</subject><subject>Patients</subject><subject>Staphylococcus aureus infections</subject><subject>Statistical analysis</subject><subject>Statistical significance</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkktvEzEQgFcIRKvSG2dkiQsShPpt7wUpCo9UalUJere83tnE1cYOtreoP4F_jaOEFDjhi1-fvvF4pmleEvyeECEuKCbthZKMC6qfNKeUET6ThJOnxzVjJ815zne4Dk0kbuXz5oThlrcCt6fNz9s1oHkpyXdTsd0I6KNP4Aq6ht47O6JFzAXFAS3BjmXtbKp4ztF5W6BHl2GosI8BLeyU60H3gK6nsfg-TSv0FbLPxQYH6CatbPB5k5EPSGq0jHnrix3zzr1Y-2BfNM-Guofzw3zWfPv86XaxnF3dfLlczK9mTkhRZlowRhThykrgWg2OW4nxQLXtOiZkx3ritOCdAmDCdUqCAqVJZ5XCPbCz5sPeup26DfQOQkl2NNvkNzY9mGi9-fsm-LVZxXsjORVMkyp4cxCk-H2CXMzGZwfjaAPEKRtKMZctlVxV9PU_6F2cUqjJGUpaVkujiX6kVnYE48MQa1y3k5q5pJwTxeUu7Ls95VLMOcFwfDLBZtcKZtcK5tAKFX_1Z5pH-HfhK_B2D9Sv7-0P_586qAwM9pEmVHEt2S9TDsTz</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Yang, Huai</creator><creator>Luo, Xiaoli</creator><creator>Xing, Yawei</creator><creator>Wu, Yinghong</creator><creator>Ding, Lili</creator><creator>Liu, Weiping</creator><creator>Lin, Ling</creator><creator>Li, Ying</creator><creator>Chen, Meilian</creator><creator>Li, Liuyi</creator><creator>Wen, Jianguo</creator><creator>Liu, Yunxi</creator><creator>Wu, Anhua</creator><creator>Yang, Yun</creator><creator>Ma, Hongqiu</creator><creator>Hou, Tieying</creator><creator>Li, Weiguang</creator><creator>Jia, Huixue</creator><creator>Zhang, Weihong</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley & Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3628-7379</orcidid></search><sort><creationdate>20190101</creationdate><title>The Attributable Direct Medical Cost of Healthcare Associated Infection Caused by Multidrug Resistance Organisms in 68 Hospitals of China</title><author>Yang, Huai ; Luo, Xiaoli ; Xing, Yawei ; Wu, Yinghong ; Ding, Lili ; Liu, Weiping ; Lin, Ling ; Li, Ying ; Chen, Meilian ; Li, Liuyi ; Wen, Jianguo ; Liu, Yunxi ; Wu, Anhua ; Yang, Yun ; Ma, Hongqiu ; Hou, Tieying ; Li, Weiguang ; Jia, Huixue ; Zhang, Weihong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c565t-853317147a6e487fc4a600f28abb356b3d1c854b7ee35cb76e7e781ba770de3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Beta lactamases</topic><topic>China</topic><topic>Cross infection</topic><topic>Drug resistance</topic><topic>Drug resistance in microorganisms</topic><topic>E coli</topic><topic>Economic aspects</topic><topic>Epidemiology</topic><topic>Escherichia coli</topic><topic>Health aspects</topic><topic>Health care</topic><topic>Hospitals</topic><topic>Infections</topic><topic>Medical care, Cost of</topic><topic>Methicillin</topic><topic>Mortality</topic><topic>Multidrug resistance</topic><topic>Multidrug resistant organisms</topic><topic>Nosocomial infections</topic><topic>Patients</topic><topic>Staphylococcus aureus infections</topic><topic>Statistical analysis</topic><topic>Statistical significance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Huai</creatorcontrib><creatorcontrib>Luo, Xiaoli</creatorcontrib><creatorcontrib>Xing, Yawei</creatorcontrib><creatorcontrib>Wu, Yinghong</creatorcontrib><creatorcontrib>Ding, Lili</creatorcontrib><creatorcontrib>Liu, Weiping</creatorcontrib><creatorcontrib>Lin, Ling</creatorcontrib><creatorcontrib>Li, Ying</creatorcontrib><creatorcontrib>Chen, Meilian</creatorcontrib><creatorcontrib>Li, Liuyi</creatorcontrib><creatorcontrib>Wen, Jianguo</creatorcontrib><creatorcontrib>Liu, Yunxi</creatorcontrib><creatorcontrib>Wu, Anhua</creatorcontrib><creatorcontrib>Yang, Yun</creatorcontrib><creatorcontrib>Ma, Hongqiu</creatorcontrib><creatorcontrib>Hou, Tieying</creatorcontrib><creatorcontrib>Li, Weiguang</creatorcontrib><creatorcontrib>Jia, Huixue</creatorcontrib><creatorcontrib>Zhang, Weihong</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Huai</au><au>Luo, Xiaoli</au><au>Xing, Yawei</au><au>Wu, Yinghong</au><au>Ding, Lili</au><au>Liu, Weiping</au><au>Lin, Ling</au><au>Li, Ying</au><au>Chen, Meilian</au><au>Li, Liuyi</au><au>Wen, Jianguo</au><au>Liu, Yunxi</au><au>Wu, Anhua</au><au>Yang, Yun</au><au>Ma, Hongqiu</au><au>Hou, Tieying</au><au>Li, Weiguang</au><au>Jia, Huixue</au><au>Zhang, Weihong</au><au>Liu, Yatao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Attributable Direct Medical Cost of Healthcare Associated Infection Caused by Multidrug Resistance Organisms in 68 Hospitals of China</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2019-01-01</date><risdate>2019</risdate><volume>2019</volume><issue>2019</issue><spage>1</spage><epage>7</epage><pages>1-7</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>Healthcare associated infection (HAI) is known to increase the economic burden of patients while the medical cost due to MDRO HAI is even higher. Three hundred eighty-one multidrug resistance organisms (MDROs) healthcare associated infection (HAI) case-patients and three hundred eighty-one matched control-patients were identified between January and December in 2015. The average total hospitalization medical cost of the case group was $6127.65 and that of the control group was $2274.02. The difference between the case group and the control group was statistically significant (t = 21.07; P < 0.01). The attributable cost of MDRO HAI was $3853.63. The direct medical costs due to different MDRO infections were different. The increased medical costs of CR-AB, CR-KP, and CR-PA were significantly higher than that of MRSA, MRSE, ESBL E. coli, and ESBL Kp (P < 0. 05). Among the subitem expenses, the drug cost increased the most (the average cost was $1457.72), followed by the treatment fee and test fee; the differences were statistically significant (P < 0.01).</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>30949509</pmid><doi>10.1155/2019/7634528</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-3628-7379</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2314-6133 |
| ispartof | BioMed research international, 2019-01, Vol.2019 (2019), p.1-7 |
| issn | 2314-6133 2314-6141 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6425381 |
| source | Wiley Online Library Open Access; PubMed Central; Alma/SFX Local Collection; PubMed Central Open Access |
| subjects | Beta lactamases China Cross infection Drug resistance Drug resistance in microorganisms E coli Economic aspects Epidemiology Escherichia coli Health aspects Health care Hospitals Infections Medical care, Cost of Methicillin Mortality Multidrug resistance Multidrug resistant organisms Nosocomial infections Patients Staphylococcus aureus infections Statistical analysis Statistical significance |
| title | The Attributable Direct Medical Cost of Healthcare Associated Infection Caused by Multidrug Resistance Organisms in 68 Hospitals of China |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T11%3A24%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Attributable%20Direct%20Medical%20Cost%20of%20Healthcare%20Associated%20Infection%20Caused%20by%20Multidrug%20Resistance%20Organisms%20in%2068%20Hospitals%20of%20China&rft.jtitle=BioMed%20research%20international&rft.au=Yang,%20Huai&rft.date=2019-01-01&rft.volume=2019&rft.issue=2019&rft.spage=1&rft.epage=7&rft.pages=1-7&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2019/7634528&rft_dat=%3Cgale_pubme%3EA624417461%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2193133818&rft_id=info:pmid/30949509&rft_galeid=A624417461&rfr_iscdi=true |